PB2104: DOSE-DENSE CHEMOTHERAPY WITH R-CHOP-14 IN OLDER ADULTS AGED ≥80 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA

• K. Christofyllakis,
• Z. G. Dilbaz,
• S. Denker,
• C. Ankermann,
• A. Kunte,
• V. Poeschel,
• M. Bewarder,
• D. Kaddu-Mulindwa,
• S. Stilgenbauer,
• L. Thurner,
• I.-K. Na,
• J.-T. Bittenbring

Affiliations

K. Christofyllakis

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

Z. G. Dilbaz

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

S. Denker

3 Medical Department, Division of Hematology, Oncology and Tumor Immunology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

C. Ankermann

3 Medical Department, Division of Hematology, Oncology and Tumor Immunology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

A. Kunte

5 Department of Stem Cell Transplantation, Hamburg-Eppendorf University Medical Center, Hamburg

V. Poeschel

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

M. Bewarder

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

D. Kaddu-Mulindwa

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

S. Stilgenbauer

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

L. Thurner

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center

I.-K. Na

3 Medical Department, Division of Hematology, Oncology and Tumor Immunology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

J.-T. Bittenbring

1 Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center